123 related articles for article (PubMed ID: 8127350)
21. Tumour lysis syndrome after treatment of chronic lymphocytic leukaemia with fludarabine.
Montalban C; Liaño F; Aguilera A
Postgrad Med J; 1994 Sep; 70(827):651-2. PubMed ID: 7971632
[TBL] [Abstract][Full Text] [Related]
22. Fulminant hepatitis C virus infection.
Schirmer M; Vogel W; Thaler J; Grünewald K; Umlauft F; Geisen F; Zilian U; Konwalinka G
Lancet; 1994 Jun; 343(8910):1433. PubMed ID: 7910911
[No Abstract] [Full Text] [Related]
23. Acute tumour lysis syndrome after oral fludarabine in a patient with chronic lymphocytic leukaemia.
Ramachandran A; Majumdar G
Hematol J; 2004; 5(6):528-9. PubMed ID: 15570297
[TBL] [Abstract][Full Text] [Related]
24. [Tumor lysis syndrome in chronic lymphoid leukemia treated with chlorambucil and prednisone].
Alliot C; Claisse JF; Desablens B
Presse Med; 1995 Sep 2-9; 24(25):1178. PubMed ID: 7567838
[No Abstract] [Full Text] [Related]
25. Lenalidomide-associated tumor flare reaction is manageable in patients with chronic lymphocytic leukemia.
Chanan-Khan AA; Whitworth A; Bangia N; Porter CW; Lee K
J Clin Oncol; 2008 Oct; 26(29):4851-2; author reply 4852-3. PubMed ID: 18779599
[No Abstract] [Full Text] [Related]
26. Factors affecting bryostatin 1-enhanced 2-CdA cytotoxicity in resistant B-cell chronic lymphocytic leukemia.
Beck FW; Eilender DS; Dandashi MH; Siddiq F; Snell DC; Godmere MA; Al-Katib AM; Mohammad RM
Int J Mol Med; 2004 Jul; 14(1):113-9. PubMed ID: 15202025
[TBL] [Abstract][Full Text] [Related]
27. Cladribine with or without prednisone in the treatment of previously treated and untreated B-cell chronic lymphocytic leukaemia - updated results of the multicentre study of 378 patients.
Robak T; Bloński JZ; Kasznicki M; Konopka L; Ceglarek B; Dmoszyńska A; Soroka-Wojtaszko M; Skotnicki AB; Nowak W; Dwilewicz-Trojaczek J; Tomaszewska A; Hellmann A; Lewandowski K; Kuliczkowski K; Potoczek S; Zdziarska B; Hansz J; Kroll R; Komarnicki M; Holowiecki J; Grieb P
Br J Haematol; 2000 Feb; 108(2):357-68. PubMed ID: 10691866
[TBL] [Abstract][Full Text] [Related]
28. Acute tumor lysis syndrome during oral fludarabine treatment for CLL--a rare event that might be observed more frequently in the future.
Rioufol C; Coiffier B
Onkologie; 2008 Apr; 31(4):157-8. PubMed ID: 18418014
[No Abstract] [Full Text] [Related]
29. BCL-2 immunohistochemical evaluation in B-cell chronic lymphocytic leukemia and hairy cell leukemia before treatment with fludarabine and 2-chloro-deoxy-adenosine.
Zaja F; Di Loreto C; Amoroso V; Salmaso F; Russo D; Silvestri F; Fanin R; Damiani D; Infanti L; Mariuzzi L; Beltrami CA; Baccarani M
Leuk Lymphoma; 1998 Feb; 28(5-6):567-72. PubMed ID: 9613987
[TBL] [Abstract][Full Text] [Related]
30. Profound toxicity of deoxyadenosine and 2-chlorodeoxyadenosine toward human monocytes in vitro and in vivo.
Carrera CJ; Yamanaka H; Piro LD; Lotz M; Carson DA
Adv Exp Med Biol; 1989; 253B():219-25. PubMed ID: 2575348
[TBL] [Abstract][Full Text] [Related]
31. Mycophenolate mofetil for severe autoimmune haemolytic anemia.
Zimmer-Molsberger B; Knauf W; Thiel E
Lancet; 1997 Oct; 350(9083):1003-4. PubMed ID: 9329520
[No Abstract] [Full Text] [Related]
32. A phase I clinical trial of 2-chlorodeoxyadenosine in pediatric patients with acute leukemia.
Santana VM; Mirro J; Harwood FC; Cherrie J; Schell M; Kalwinsky D; Blakley RL
J Clin Oncol; 1991 Mar; 9(3):416-22. PubMed ID: 1671875
[TBL] [Abstract][Full Text] [Related]
33. The mechanism of 2-chlorodeoxyadenosine-induced cell death.
Wataya Y; Hirota Y; Hiramoto-Yoshioka A; Tanaka S; Otani T; Minowada J; Matsuda A; Ueda T
Adv Exp Med Biol; 1989; 253B():227-34. PubMed ID: 2575349
[No Abstract] [Full Text] [Related]
34. Pneumatic tube "pseudo tumor lysis syndrome" in chronic lymphocytic leukemia.
Chawla NR; Shapiro J; Sham RL
Am J Hematol; 2009 Sep; 84(9):613-4. PubMed ID: 19610017
[No Abstract] [Full Text] [Related]
35. Association of myelodysplastic changes with purine analogues.
Orchard JA; Bolam S; Oscier DG
Br J Haematol; 1998 Mar; 100(4):677-9. PubMed ID: 9531333
[TBL] [Abstract][Full Text] [Related]
36. Oral antilymphocyte activity and induction of apoptosis by 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine.
Carson DA; Wasson DB; Esparza LM; Carrera CJ; Kipps TJ; Cottam HB
Proc Natl Acad Sci U S A; 1992 Apr; 89(7):2970-4. PubMed ID: 1348362
[TBL] [Abstract][Full Text] [Related]
37. Acute tumor lysis syndrome induced by high-dose corticosteroids in a patient with chronic lymphatic leukemia.
Vaisban E; Zaina A; Braester A; Manaster J; Horn Y
Ann Hematol; 2001 May; 80(5):314-5. PubMed ID: 11446738
[TBL] [Abstract][Full Text] [Related]
38. Treatment-Emergent Tumor Lysis Syndrome With PI3Kδ-γ Inhibition After CAR T-Cell Therapy for Chronic Lymphocytic Leukemia.
Shah NN; Jerkins JH; Johnson BD; Hari P
JCO Oncol Pract; 2020 Sep; 16(9):613-614. PubMed ID: 32603254
[No Abstract] [Full Text] [Related]
39. [A new effective therapy of hairy cell leukemia and other lymphoproliferative diseases].
Juliusson G; Liliemark J
Lakartidningen; 1991 Aug; 88(35):2746-9. PubMed ID: 1680209
[No Abstract] [Full Text] [Related]
40. 2-Chlorodeoxyadenosine treatment of lymphoid malignancies.
Piro LD
Blood; 1992 Feb; 79(4):843-5. PubMed ID: 1346575
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
